SILV could be a melanogenic enzyme. It could represent an oncofetal self-antigen that is normally expressed at low levels in quiescent adult melanocytes but overexpressed by proliferating neonatal melanocytes and during tumor growth. Release of the soluble form, ME20-S, it could protect tumor cells from antibody mediated immunity.
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Human kidney
PMEL was immunoprecipitated from 1 mg HEK293 Whole Cell Lysate with ARP46802_T100 with 1:200 dilution. Western blot was performed using ARP46802_T100 at 1/1000 dilution. Lane 1: Control IP in HEK293 Whole Cell Lysate. Lane 2: PMEL IP with ARP46802_T100 in HEK293 Whole Cell Lysate. Lane 3: Input of HEK293 Whole Cell Lysate.